FDA — authorised 26 June 1986
- Marketing authorisation holder: HOSPIRA
- Status: approved
🇺🇸 Chromic Chloride In Plastic Container in United States
FDA authorised Chromic Chloride In Plastic Container on 26 June 1986
Marketing authorisations
FDA — authorised 26 June 1986
- Application: NDA018961
- Marketing authorisation holder: HOSPIRA
- Local brand name: CHROMIC CHLORIDE IN PLASTIC CONTAINER
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 5 May 1987
- Application: NDA019271
- Marketing authorisation holder: ABRAXIS PHARM
- Local brand name: CHROMIC CHLORIDE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 18 November 2024
- Application: ANDA218538
- Marketing authorisation holder: SOMERSET THERAPS LLC
- Local brand name: CHROMIC CHLORIDE
- Indication: INJECTABLE — INJECTION
- Status: approved
Chromic Chloride In Plastic Container in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Chromic Chloride In Plastic Container approved in United States?
Yes. FDA authorised it on 26 June 1986; FDA authorised it on 26 June 1986; FDA authorised it on 5 May 1987.
Who is the marketing authorisation holder for Chromic Chloride In Plastic Container in United States?
HOSPIRA holds the US marketing authorisation.